Drug Profile
Banoxantrone
Alternative Names: AQ4N; AZD 1689Latest Information Update: 21 Aug 2019
Price :
$50
*
At a glance
- Originator University of London School of Pharmacy
- Developer Novacea; Transcept Pharmaceuticals Inc
- Class Anthraquinones; Antineoplastics; Small molecules
- Mechanism of Action DNA intercalators; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued B-cell lymphoma; Glioblastoma; Precursor cell lymphoblastic leukaemia-lymphoma